{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T20:47:50Z","timestamp":1740170870551,"version":"3.37.3"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:00:00Z","timestamp":1606521600000},"content-version":"vor","delay-in-days":393,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Infectious Disease Clinical Research Program"},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007188","name":"Uniformed Services University of the Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007188","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Preventive Medicine and Biostatistics"},{"name":"U.S. DoD"},{"DOI":"10.13039\/100009898","name":"Defense Health Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009898","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Global Emerging Infections Surveillance","award":["P0118_18_HS"],"award-info":[{"award-number":["P0118_18_HS"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Sexually transmitted infections (STIs) continue to plague militaries and defense forces. While the historical recognition of the impact of STIs on operations is evident, contemporary surveillance and research activities are limited. As Neisseria gonorrhoeae and other sexually transmitted pathogens become increasingly resistant to antibiotics, the role of the Department of Defense (DoD) in disease surveillance and clinical research is essential to military Force Health Protection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences partnered with the DoD Global Emerging Infections Surveillance (GEIS) program to monitor the distribution of gonorrhea antimicrobial resistance (AMR) both domestically and abroad. The DoD gonococcal reference laboratory and repository was established in 2011 as a resource for confirmatory testing and advanced characterization of isolates collected from sites across the continental United States (CONUS) and GEIS-funded sites outside the continental United States (OCONUS). The IDCRP is currently implementing surveillance efforts at CONUS military clinics, including Madigan Army Medical Center, Naval Medical Center Camp Lejeune, Naval Medical Center Portsmouth, Naval Medical Center San Diego, and San Antonio Military Medical Center (efforts were also previously at Womack Army Medical Center). The reference laboratory and repository receives specimens from OCONUS collaborators, including Armed Forces Research Institute of Medical Sciences (AFRIMS; Bangkok, Thailand), Naval Medical Research Unit No. 3 (NAMRU-3), Ghana Detachment (Accra, Ghana), Naval Medical Research Unit No. 6 (NAMRU-6; Lima, Peru), U.S. Army Medical Research Unit \u2013 Georgia (USAMRD-G; Tbilisi, Republic of Georgia), and U.S. Army Medical Research Directorate \u2013 Kenya (USAMRD-K; Nairobi, Kenya). The gonococcal surveillance program, to include findings, as well as associated clinical research efforts are described.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among N. gonorrhoeae isolates tested within the United States, 8% were resistant to tetracycline, 2% were resistant to penicillin, and 30% were resistant to ciprofloxacin. To date, only one of the 61 isolates has demonstrated some resistance (MIC=1 \u03bcg\/ml) to azithromycin. No resistance to cephalosporins has been detected; however, reduced susceptibility (MIC=0.06\u20130.125 \u03bcg\/ml) has been observed in 13% of isolates. Resistance is commonly observed in N. gonorrhoeae isolates submitted from OCONUS clinical sites, particularly with respect to tetracycline, penicillin, and ciprofloxacin. While no azithromycin-resistant isolates have been identified from OCONUS sites, reduced susceptibility (MIC=0.125\u20130.5 \u03bcg\/ml) to azithromycin was observed in 23% of isolates.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Continued monitoring of circulating resistance patterns on a global scale is critical for ensuring appropriate treatments are prescribed for service members that may be infected in the U.S. or while deployed. Domestic surveillance for gonococcal AMR within the Military Health System has indicated that resistance patterns, while variable, are not dramatically different from what is seen in U.S. civilian data. Global patterns of gonococcal AMR have been described through the establishment of a central DoD gonococcal reference laboratory and repository. This repository of global isolates provides a platform for further research and development into biomedical countermeasures against gonococcal infections.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/milmed\/usy431","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T13:10:44Z","timestamp":1574946644000},"page":"51-58","source":"Crossref","is-referenced-by-count":2,"title":["Biomedical Response to <i>Neisseria gonorrhoeae<\/i> and Other Sexually Transmitted Infections in the US Military"],"prefix":"10.1093","volume":"184","author":[{"given":"Eric","family":"Garges","sequence":"first","affiliation":[{"name":"Infectious Disease Clinical Research Program, Department of Preventive Medicine & Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June","family":"Early","sequence":"additional","affiliation":[{"name":"Infectious Disease Clinical Research Program, Department of Preventive Medicine & Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814"},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Bethesda, MD 20817"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Waggoner","sequence":"additional","affiliation":[{"name":"Infectious Disease Clinical Research Program, Department of Preventive Medicine & Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814"},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Bethesda, MD 20817"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazia","family":"Rahman","sequence":"additional","affiliation":[{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Bethesda, MD 20817"},{"name":"Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Golden","sequence":"additional","affiliation":[{"name":"Infectious Disease Clinical Research Program, Department of Preventive Medicine & Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814"},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Bethesda, MD 20817"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Agan","sequence":"additional","affiliation":[{"name":"Infectious Disease Clinical Research Program, Department of Preventive Medicine & Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814"},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Bethesda, MD 20817"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Jerse","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,11,28]]},"reference":[{"issue":"2","key":"2020120619045154200_usy431C1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2105\/AJPH.8.2.107-a","article-title":"Venereal diseases and the war","volume":"VIII","author":"Gorgas","year":"1918","journal-title":"Am J Public Health"},{"key":"2020120619045154200_usy431C2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00007435-198204000-00011","article-title":"Venereal disease in the United States Army: 1775\u20131900","volume":"9","author":"Kampmeier","year":"1982","journal-title":"Sex Transm Dis"},{"author":"McNinch","key":"2020120619045154200_usy431C3"},{"issue":"12","key":"2020120619045154200_usy431C4","doi-asserted-by":"crossref","first-page":"e0167892","DOI":"10.1371\/journal.pone.0167892","article-title":"The association between sexually transmitted infections, length of service and other demographic factors in the U.S. Military","volume":"11","author":"Deiss","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"2020120619045154200_usy431C5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/OLQ.0000000000000133","article-title":"Self-reported sexually transmitted infections and sexual risk behaviors in the U.S. Military: how sex influences risk","volume":"41","author":"Stahlman","year":"2014","journal-title":"Sex Transm Dis"},{"issue":"9","key":"2020120619045154200_usy431C6","first-page":"15","article-title":"Sexually transmitted infections, active component, U.S. Armed Forces, 2007\u20132016","volume":"24","author":"Stahlman","year":"2017","journal-title":"MSMR"},{"issue":"1","key":"2020120619045154200_usy431C7","first-page":"12","article-title":"Rates of Chlamydia trachomatis infections across the deployment cycle, active component, U.S. Armed Forces, 2008\u20132015","volume":"24","author":"Stahlman","year":"2017","journal-title":"MSMR"},{"issue":"4","key":"2020120619045154200_usy431C8","doi-asserted-by":"crossref","first-page":"e0195158","DOI":"10.1371\/journal.pone.0195158","article-title":"Prevalence and risk factors of sexually transmitted infections among French service members","volume":"13","author":"Duron","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"2020120619045154200_usy431C9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1370\/afm.337","article-title":"Screening for gonorrhea: recommendation statement","volume":"3","author":"US Preventive Services Task Force","year":"2005","journal-title":"Ann Fam Med"},{"issue":"9","key":"2020120619045154200_usy431C10","first-page":"2","article-title":"Review of the U.S. military\u2019s Human Immunodeficiency Virus program: a legacy of progress and a future of promise","volume":"24","author":"Okulicz","year":"2017","journal-title":"MSMR"},{"author":"Centers for Disease Control and Prevention","key":"2020120619045154200_usy431C11"},{"issue":"12","key":"2020120619045154200_usy431C12","doi-asserted-by":"crossref","first-page":"e0143304","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting","volume":"10","author":"Newman","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"2020120619045154200_usy431C13","doi-asserted-by":"crossref","first-page":"e1002344","DOI":"10.1371\/journal.pmed.1002344","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action","volume":"14","author":"Wi","year":"2017","journal-title":"PLoS Med"},{"key":"2020120619045154200_usy431C14","volume-title":"Sexually Transmitted Diseases","author":"Holmes","year":"2007","edition":"Ed 4"},{"issue":"3","key":"2020120619045154200_usy431C15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"2020120619045154200_usy431C16","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/S1473-3099(17)30310-9","article-title":"Sexually transmitted infections: challenges ahead","volume":"17","author":"Unemo","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"25","key":"2020120619045154200_usy431C17","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMc1512757","article-title":"Failure of dual antimicrobial therapy in treatment of gonorrhea","volume":"374","author":"Fifer","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"2020120619045154200_usy431C18","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3201\/eid2305.170088","article-title":"Azithromycin resistance and decreased ceftriaxone susceptibility in Neisseria gonorrhoeae, Hawaii, USA","volume":"23","author":"Papp","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"2020120619045154200_usy431C19","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/cid\/cix485","article-title":"Cluster of Neisseria gonorrhoeae isolates with high-level azithromycin resistance and decreased ceftriaxone susceptibility, Hawaii, 2016","volume":"65","author":"Katz","year":"2017","journal-title":"Clin Infect Dis"},{"author":"Gallagher","key":"2020120619045154200_usy431C20"},{"author":"Senthilingam","key":"2020120619045154200_usy431C21"},{"issue":"10","key":"2020120619045154200_usy431C22","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1177\/0956462416681940","article-title":"Repeat infection with Neisseria gonorrhoeae among active duty U.S. Army personnel: a population-based case-series study","volume":"28","author":"Bautista","year":"2017","journal-title":"Int J STD AIDS"},{"issue":"12","key":"2020120619045154200_usy431C23","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.7205\/MILMED-D-13-00137","article-title":"Expanded sexually transmitted infection surveillance efforts in the United States military: a time for action","volume":"178","author":"Sanchez","year":"2013","journal-title":"Mil Med"},{"issue":"2","key":"2020120619045154200_usy431C24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00007435-197804000-00003","article-title":"Dynamics and control of the transmission of gonorrhea","volume":"5","author":"Yorke","year":"1978","journal-title":"Sex Transm Dis"},{"year":"2015","author":"Clinical and Laboratory Standards Institute","key":"2020120619045154200_usy431C25"},{"issue":"27","key":"2020120619045154200_usy431C26","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.27.1800323","article-title":"Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018","volume":"23","author":"Eyre","year":"2018","journal-title":"Euro Surveill"},{"issue":"5","key":"2020120619045154200_usy431C27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1473-3099(18)30122-1","article-title":"Sustained transmission of high-level azithromycin-resistant Neisseria gonorrhoeae in England: an observational study","volume":"18","author":"Fifer","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"2020120619045154200_usy431C28","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3201\/eid2310.170488","article-title":"Antimicrobial drug prescription and Neisseria gonorrhoeae susceptibility, United States, 2005\u20132013","volume":"23","author":"Kirkcaldy","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"2020120619045154200_usy431C29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/antibiotics7030058","article-title":"Trends in Neisseria gonorrhoeae antimicrobial resistance over a ten-year surveillance period, Johannesburg, South Africa, 2008\u20132017","volume":"7","author":"Kularatne","year":"2018","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"2020120619045154200_usy431C30","first-page":"16","article-title":"Sexually transmitted infections in U.S. Air Force recruits in basic military training","volume":"23","author":"Webber","year":"2016","journal-title":"MSMR"},{"issue":"9","key":"2020120619045154200_usy431C31","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s10096-017-2969-9","article-title":"Multidrug-resistant Mycoplasma genitalium infections in Europe","volume":"36","author":"Braam","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"2020120619045154200_usy431C32","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2340\/00015555-2746","article-title":"Mycoplasma genitalium and macrolide resistance-associated mutations in the Skane Region of Southern Sweden 2015","volume":"97","author":"Forslund","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"2020120619045154200_usy431C33","article-title":"Outcomes of resistance-guided sequential treatment of Mycoplasma genitalium infections: a prospective evaluation","author":"Read","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2020120619045154200_usy431C34","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1099\/jmm.0.000584","article-title":"High levels of macrolide-resistant Mycoplasma genitalium in Queensland, Australia","volume":"66","author":"Trembizki","year":"2017","journal-title":"J Med Microbiol"},{"key":"2020120619045154200_usy431C35","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev-micro-090816-093530","article-title":"Neisseria gonorrhoeae: drug resistance, mouse models, and vaccine development","volume":"71","author":"Rice","year":"2017","journal-title":"Annu Rev Microbiol"},{"key":"2020120619045154200_usy431C36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jtbi.2016.09.004","article-title":"In-silico hierarchical pproach for the identification of potential universal vaccine candidates (PUVCs) from Neisseria gonorrhoeae","volume":"410","author":"Jain","year":"2016","journal-title":"J Theor Biol"},{"issue":"6","key":"2020120619045154200_usy431C37","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/mi.2017.11","article-title":"Experimental vaccine induces Th1-driven immune responses and resistance to Neisseria gonorrhoeae infection in a murine model","volume":"10","author":"Liu","year":"2017","journal-title":"Mucosal Immunol"},{"issue":"10102","key":"2020120619045154200_usy431C38","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study","volume":"390","author":"Petousis-Harris","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"2020120619045154200_usy431C39","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1074\/mcp.M116.058800","article-title":"Proteomics-driven antigen discovery for development of vaccines against gonorrhea","volume":"15","author":"Zielke","year":"2016","journal-title":"Mol Cell Proteomics"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/milmed\/article-pdf\/184\/Supplement_2\/51\/31616679\/usy431.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/milmed\/article-pdf\/184\/Supplement_2\/51\/31616679\/usy431.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:12:19Z","timestamp":1607299939000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/184\/Supplement_2\/51\/5645092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":39,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2019,11,28]]},"published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usy431","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"type":"print","value":"0026-4075"},{"type":"electronic","value":"1930-613X"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,11,1]]}}}